Beam Therapeutics Insider Sells $146K in Shares

Christine Bellon, a Beam Therapeutics insider, sold nearly 6,000 shares of the company's stock.

Apr. 6, 2026 at 10:13pm

Got story updates? Submit your updates here. ›

An extreme close-up of gears, levers, and other industrial banking equipment, conveying the intricate financial infrastructure behind a biotech company's stock transactions.An insider's stock sale highlights the complex financial mechanics behind a biotech company's operations.Philadelphia Today

Beam Therapeutics Inc. (NASDAQ:BEAM) insider Christine Bellon sold 5,956 shares of the company's stock on Wednesday, April 1st. The shares were sold at an average price of $24.58, for a total transaction value of $146,398.48. Following the sale, Bellon still owns 109,711 shares in the company, valued at $2,696,696.38.

Why it matters

Insider trading activity can provide insights into a company's performance and the sentiment of its leadership. Bellon's sale represents a 5.15% decrease in her ownership stake, which may signal some uncertainty or a need to raise personal funds.

The details

The sale was executed under a pre-arranged Rule 10b5-1 trading plan, and the proceeds were used to cover tax withholding obligations related to the vesting of Bellon's equity awards. Beam Therapeutics is a biotechnology company focused on developing precision genetic medicines using its base editing platform.

  • The shares were sold on Wednesday, April 1st, 2026.
  • Bellon previously sold 1,371 shares on January 22nd and 18,629 shares on January 15th.

The players

Christine Bellon

An insider at Beam Therapeutics who sold 5,956 shares of the company's stock.

Beam Therapeutics Inc.

A biotechnology company dedicated to developing precision genetic medicines through its pioneering base editing platform.

Got photos? Submit your photos here. ›

The takeaway

Insider trading activity can provide insights into a company's performance and the sentiment of its leadership. While Bellon's sale represents a decrease in her ownership stake, it was executed as part of a pre-arranged plan to cover tax obligations, rather than a broader shift in her outlook on the company.